Manufacturing science and technology continues to play an essential role in enabling biopharmaceutical innovation. While biopharmaceuticals comprise multiple molecular formats, there are important similarities connecting the different production platforms used for manufacturing. This connectivity provides ample opportunities to share key knowledge and learning across various product types and associated scientific disciplines. In line with its mission of connecting people, science and regulation, PDA Europe has recognized the need for a forum to communicate information and facilitate interaction in the field of biopharmaceutical manufacturing. Following a successful inaugural event in 2019, PDA Europe is proud to announce the second edition of its BioManufacturing Conference to be held on 22-23 September 2020 in Dublin/Ireland.
The 2020 conference will provide an exceptional opportunity to present the latest innovative approaches for biopharmaceutical manufacturing and discuss hot topics related to process, product, analytics and regulatory strategies with a broad audience, including representatives from companies, academic research institutions, regulatory agencies and Official Medicines Control Laboratories. A variety of biopharmaceutical product classes will be considered, including Therapeutic Proteins and Vaccines. Examples of the types of topics in scope for the conference are listed in the call for abstracts.
Michael De Felippis, PhDEli Lilly and CompanyCristiana Campa, PhDGSK Vaccine
Manufacturing science and technology continues to play an essential role in enabling biopharmaceutical innovation. While biopharmaceuticals comprise multiple molecular formats, there are important simi ...Mehr Informationen >>